Volume 77, Issue 3
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645


A 48-year-old immunocompetent man without known exposure to tuberculosis had a > 10-year history of recurrent skin lesions. Cutaneous tuberculosis without any current or past history of pulmonary tuberculosis was diagnosed. Culture of biopsy specimens showed the organism to be resistant to multiple first-line and second-line agents. The patient had a broad, vigorous CD4-specific immune response against multiple tuberculosis antigens. This case is the first report of cutaneous extensively drug-resistant tuberculosis.


Article metrics loading...

The graphs shown below represent data from March 2017
Loading full text...

Full text loading...



  1. South African National Tuberculosis Control Programme, 2004. The South African National Tuberculosis Control Programme Practical Guidelines. Pretoria, South Africa: South African National Tuberculosis Control Programme.
  2. Pitcher CJ, Quittner C, Peterson DM, Connors M, Koup RA, Maino VC, Picker LY, 1999. HIV-1-specific CD4+ T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression. Nat Med 5 : 518–525. [Google Scholar]
  3. World Health Organization, 2006. WHO Global Task Force Outlines Measures to Combat XDR-TB Worldwide. Accessed June 11, 2007. Available from http://www.who.int/mediacentre/news/notes/2006/np29/en/index.html
  4. Ramam M, Mittal R, Ramesh V, 2005. How soon does cutaneous tuberculosis respond to treatment? Implications for a therapeutic test of diagnosis. Int J Dermatol 44 : 121–124. [Google Scholar]
  5. Dye C, Scheele S, Dolin P, Pathania V, Raviglione MC, 1999. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA 282 : 677–686. [Google Scholar]
  6. Golden MP, Vikram HR, 2005. Extrapulmonary tuberculosis: an overview. Am Fam Physician 72 : 1761–1768. [Google Scholar]
  7. Gopinathan RPD, Joshi J, Jerajani H, Mathur M, 2001. Clinical and morphological variants of cutaneous tuberculosis and its relation to Mycobacterium species. Indian J Med Microbiol 19 : 193–196. [Google Scholar]
  8. Ho CK, Ho MH, Chong LY, 2006. Cutaneous tuberculosis in Hong Kong: an update. Hong Kong Med J 12 : 272–277. [Google Scholar]
  9. Friedman PC, Husain S, Grossman ME, 2005. Nodular tuberculid in a patient with HIV. J Am Acad Dermatol 53 : S154–S156. [Google Scholar]
  10. Barbagallo J, Tager P, Ingleton R, Hirsch RJ, Weinberg JM, 2002. Cutaneous tuberculosis: diagnosis and treatment. Am J Clin Dermatol 3 : 319–328. [Google Scholar]
  11. Ramesh V, Murlidhar S, Kumar J, Srivastava L, 2001. Isolation of drug-resistant tubercle bacilli in cutaneous tuberculosis. Pediatr Dermatol 18 : 393–395. [Google Scholar]
  12. U.S. Centers for Disease Control and Prevention, 2006. Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs–worldwide, 2000–2004. MMWR Morb Mortal Wkly Rep 55 : 301–305. [Google Scholar]
  13. 1975. Tuberculosis in Tanzania: a national sampling survey of drug resistance and other factors. Tubercle 56 : 269–294. [Google Scholar]
  14. Ginsburg AS, Hooper N, Parrish N, Dooley KE, Dorman SE, Booth J, Diener-West M, Merz WG, Bishai WR, Sterling TR, 2003. Fluoroquinolone resistance in patients with newly diagnosed tuberculosis. Clin Infect Dis 37 : 1448–1452. [Google Scholar]

Data & Media loading...

  • Received : 02 Apr 2007
  • Accepted : 18 Jun 2007

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error